Related Experiment Video
Updated: Aug 8, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
High-precision radiotherapy: where are we going and how do we get there?
1Department of Radiation Oncology, London Regional Cancer Program, University of Western Ontario, London, Ontario, Canada.
The Canadian Journal of Urology
|May 5, 2006
Summary
Advancements in prostate cancer radiotherapy, including dose escalation and hypofractionated treatment, aim to improve outcomes. Accurate tumor localization techniques are crucial for enhancing treatment efficacy and minimizing toxicity.
Area of Science:
- Urology
- Radiation Oncology
- Medical Physics
Background:
- Physicians convened at the 4th Annual Current Problems in Urology Conference to discuss urologic cancer patient care.
- A key focus was technical challenges in prostate cancer radiotherapy, addressing future directions and implementation strategies.
- Discussions were informed by work from Princess Margaret Hospital (PMH) and London Regional Cancer Program (LRCP).
Purpose of the Study:
- To review progress and future directions in prostate cancer radiotherapy.
- To explore methods for improving treatment outcomes through dose escalation and hypofractionated regimens.
- To identify and discuss techniques for accurate prostate tumor localization to optimize treatment delivery.
Main Methods:
- Review of current practices and preliminary implementation of hypofractionated treatment.
- Detailed analysis of treatment toxicity associated with dose escalation.
- Discussion of various imaging and localization techniques, including 3D ultrasound, fiducial markers, megavoltage CT, and cone beam CT.
- Presentation of underlying research supporting the selection and implementation of these localization options.
Main Results:
- Dose escalation in prostate cancer radiotherapy shows potential for improved outcomes.
- Hypofractionated treatment is being preliminarily implemented, with careful consideration of toxicity.
- Accurate prostate localization is increasingly critical for effective dose escalation and toxicity reduction.
- Several localization options, including advanced imaging, were presented as viable for clinical implementation.
Conclusions:
- Future prostate cancer radiotherapy involves exploring dose escalation and hypofractionation for better outcomes.
- Precise tumor localization is paramount for safe and effective radiotherapy, especially with escalated doses.
- Technological advancements in imaging and localization provide options for centers to improve treatment accuracy.
Related Concept Videos
01:28Isotopes and Radioisotopes
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...
An isotope containing more...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...